Latest Insider Transactions at Enhabit, Inc. (EHAB)
This section provides a real-time view of insider transactions for Enhabit, Inc. (EHAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Enhabit, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Enhabit, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2025
|
Collin Mc Quiddy Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,096
-100.0%
|
$8,768
$8.58 P/Share
|
|
Mar 07
2025
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,457
+22.64%
|
$139,656
$8.02 P/Share
|
|
Mar 07
2025
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
19,452
+29.19%
|
$155,616
$8.02 P/Share
|
|
Mar 07
2025
|
Ryan Solomon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,173
+17.58%
|
$249,384
$8.02 P/Share
|
|
Mar 07
2025
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
133,541
+18.75%
|
$1,068,328
$8.02 P/Share
|
|
Mar 07
2025
|
Collin Mc Quiddy Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+50.0%
|
$47,888
$8.02 P/Share
|
|
Mar 07
2025
|
Julie Diane Jolley EVP of Home Health Operations |
BUY
Grant, award, or other acquisition
|
Direct |
24,439
+20.94%
|
$195,512
$8.02 P/Share
|
|
Mar 06
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,604
-5.82%
|
$20,832
$8.02 P/Share
|
|
Mar 06
2025
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,638
+14.57%
|
$61,104
$8.02 P/Share
|
|
Mar 06
2025
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,272
-8.98%
|
$10,176
$8.02 P/Share
|
|
Mar 06
2025
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,287
+23.23%
|
$34,296
$8.02 P/Share
|
|
Mar 06
2025
|
Dylan C Black General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,775
-9.1%
|
$22,200
$8.02 P/Share
|
|
Mar 06
2025
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,638
+20.03%
|
$61,104
$8.02 P/Share
|
|
Mar 06
2025
|
Ryan Solomon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-0.23%
|
$2,160
$8.02 P/Share
|
|
Mar 06
2025
|
Ryan Solomon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
910
+0.78%
|
$7,280
$8.02 P/Share
|
|
Mar 06
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,833
-2.38%
|
$86,664
$8.02 P/Share
|
|
Mar 06
2025
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,822
+5.75%
|
$222,576
$8.02 P/Share
|
|
Mar 06
2025
|
Collin Mc Quiddy Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-29.7%
|
$3,704
$8.02 P/Share
|
|
Mar 06
2025
|
Collin Mc Quiddy Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,559
+50.0%
|
$12,472
$8.02 P/Share
|
|
Mar 06
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,377
-4.06%
|
$19,016
$8.02 P/Share
|
|
Mar 06
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
7,092
+10.81%
|
$56,736
$8.02 P/Share
|
|
Mar 06
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,924
-4.13%
|
$23,392
$8.02 P/Share
|
|
Mar 06
2025
|
Julie Diane Jolley EVP of Home Health Operations |
BUY
Grant, award, or other acquisition
|
Direct |
8,510
+10.74%
|
$68,080
$8.02 P/Share
|
|
Mar 01
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,997
-4.03%
|
$143,976
$8.37 P/Share
|
|
Mar 01
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
3,041
-5.58%
|
$24,328
$8.37 P/Share
|
|
Mar 01
2025
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,148
-10.41%
|
$9,184
$8.37 P/Share
|
|
Mar 01
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,821
-5.78%
|
$30,568
$8.37 P/Share
|
|
Mar 01
2025
|
Dylan C Black General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,609
-10.24%
|
$20,872
$8.37 P/Share
|
|
Mar 01
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,374
-8.33%
|
$26,992
$8.37 P/Share
|
|
Feb 25
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-0.85%
|
$2,768
$8.26 P/Share
|
|
Feb 25
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-0.61%
|
$2,672
$8.26 P/Share
|
|
Feb 25
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-0.92%
|
$4,912
$8.26 P/Share
|
|
Feb 25
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,973
-1.76%
|
$63,784
$8.26 P/Share
|
|
Jan 10
2025
|
Mark W Ohlendorf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+10.92%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+4.23%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Stuart M Mcguigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+4.66%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,045
+6.63%
|
$21,315
$7.8 P/Share
|
|
Jan 10
2025
|
Gregory S Rush Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,205
+5.96%
|
$22,435
$7.8 P/Share
|
|
Jan 10
2025
|
Erin Hoeflinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,045
+5.6%
|
$21,315
$7.8 P/Share
|
|
Jan 10
2025
|
Jeffrey Bolton Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,808
+4.46%
|
$33,656
$7.8 P/Share
|
|
Jan 01
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,458
-2.5%
|
$24,206
$7.81 P/Share
|
|
Jan 01
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,834
-1.8%
|
$117,838
$7.81 P/Share
|
|
Jan 01
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,687
-1.5%
|
$11,809
$7.81 P/Share
|
|
Jan 01
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,800
-2.13%
|
$12,600
$7.81 P/Share
|
|
Dec 12
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
4,000
+3.92%
|
$32,000
$8.69 P/Share
|
|
Dec 10
2024
|
Stuart M Mcguigan Director |
BUY
Open market or private purchase
|
Direct |
15,000
+24.27%
|
$120,000
$8.81 P/Share
|
|
Nov 12
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
3,000
+3.09%
|
$21,000
$7.6 P/Share
|
|
Nov 08
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
7,000
+3.64%
|
$49,000
$7.76 P/Share
|
|
Oct 10
2024
|
Mark W Ohlendorf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,633
+13.27%
|
$18,431
$7.12 P/Share
|
|
Oct 10
2024
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,336
+7.73%
|
$23,352
$7.12 P/Share
|